.svg){kind=small}
Discover opportunities months before the RFP drops
Learn more →Discover opportunities months before the RFP drops
Learn more →Retrieving RFP details
Starbridge can help you:
Pain points mentioned in board meetings and strategic plans
Instantly outline and draft all requirements
Bring in your USPs and exploit competitor gaps
Starbridge can help you:
Get ahead of RFPs — target accounts planning budget or ending contracts soon
Accounts with contract expirations, meetings mentioning your product, grants, budget changes and more
Starbridge.ai books 30 - 40% of leads into meetings
Premium
Access the largest public sector contact database
Premium
Get complete source documentation & analysis
Development of candidate biodosimetry signatures/devices or MCMs to assess injuries and/or reduce mortality and/or major morbidities associated with exposure to radiation.
Starbridge can help you:
Pain points mentioned in board meetings and strategic plans
Instantly outline and draft all requirements
Bring in your USPs and exploit competitor gaps
Starbridge can help you:
Get ahead of RFPs — target accounts planning budget or ending contracts soon
Accounts with contract expirations, meetings mentioning your product, grants, budget changes and more
Starbridge.ai books 30 - 40% of leads into meetings
To catalyze innovation in advanced research development (R&D), manufacturing, procurement of medical countermeasures (MCMs). These lifesaving MCMS are needed to protect people during public health emergencies from threats such as chemical, biological, radiological, nuclear (CBRN) incidents (whether accidental OR intentional), pandemic influenza, COVID-19, other emerging infectious diseases. BARDA works closely with interagency partners through the public health emergency medical countermeasures enterprise (PHEMCE) to ensure a coordinated, whole-of-government approach to MCM preparedness response.
Posted Date
Sep 28, 2023
Due Date
Sep 25, 2028
Release: Sep 28, 2023
Close: Sep 25, 2028
To catalyze innovation in advanced research development (R&D), manufacturing, procurement of medical countermeasures (MCMs). These lifesaving MCMS are needed to protect people during public health emergencies from threats such as chemical, biological, radiological, nuclear (CBRN) incidents (whether accidental OR intentional), pandemic influenza, COVID-19, other emerging infectious diseases. BARDA works closely with interagency partners through the public health emergency medical countermeasures enterprise (PHEMCE) to ensure a coordinated, whole-of-government approach to MCM preparedness response.
AvailableThe Arkansas Department of Transportation (ARDOT) seeks proposals for research to develop and validate Arkansas-specific Crash Modification Factors (CMFs) for various roadway safety countermeasures, including new and commonly used types, to improve the accuracy of safety evaluations and investment decisions.
Posted Date
-
Due Date
Feb 13, 2026
Close: Feb 13, 2026
The Arkansas Department of Transportation (ARDOT) seeks proposals for research to develop and validate Arkansas-specific Crash Modification Factors (CMFs) for various roadway safety countermeasures, including new and commonly used types, to improve the accuracy of safety evaluations and investment decisions.
AvailableCompact Oxygen generation medical devices: compact Oxygen generation, medical (COGM) and compact Oxygen generation, medical - at altitude (COGM-A).
Posted Date
Jan 22, 2026
Due Date
Mar 6, 2026
Release: Jan 22, 2026
Close: Mar 6, 2026
Compact Oxygen generation medical devices: compact Oxygen generation, medical (COGM) and compact Oxygen generation, medical - at altitude (COGM-A).
AvailableThe Defense Health Agency is soliciting Request for Prototype Proposals for the development of compact oxygen generation medical devices across two focus areas: COGM and COGM-A. The solicitation requires devices to meet specified flow-rate and performance attributes, including FDA regulatory strategies and manufacturing plans. Proposals are due by March 6, 2026, and the official posting includes the Statement of Objectives and other technical attachments.
Posted Date
Jan 22, 2026
Due Date
Mar 6, 2026
Release: Jan 22, 2026
Close: Mar 6, 2026
The Defense Health Agency is soliciting Request for Prototype Proposals for the development of compact oxygen generation medical devices across two focus areas: COGM and COGM-A. The solicitation requires devices to meet specified flow-rate and performance attributes, including FDA regulatory strategies and manufacturing plans. Proposals are due by March 6, 2026, and the official posting includes the Statement of Objectives and other technical attachments.
AvailableSurface intent from meeting minutes, budgets, and contract expirations. Influence RFP requirements before competitors ever see them.
See your top 10 upcoming opportunities on a demo →Premium
Access the largest public sector contact database
Premium
Get complete source documentation & analysis